Publications by authors named "Isabelle Borget"

Claim this Profile
B
Baseline CT-derived tumor burden and liquid biopsy as biomarkers to predict survival in patients with metastatic solid cancer.
Ghina Jardali, Littisha Lawrance, Lama Dawi, Jules Dupont, Othilie Gautier, Isabelle Borget

Diagn Interv Imaging· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics, healthcare resource use, and survival outcomes among patients with advanced NSCLC tested for KRAS mutations in France, the United Kingdom, and Switzerland.
Marie Wislez, Andromachi Giannopoulou, Isabelle Borget, Colin Lindsay, Sacha I Rothschild

J Med Econ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficiency of Gla-300 versus Gla-100 Across Age Groups in People Living with Type 2 Diabetes in France: A Post Hoc Analysis of an Observational Longitudinal Study.
Patrice Darmon, Olivier Hanon, Pierre Gourdy, Isabelle Borget, Bruno Detournay

Adv Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncology pharmacy practice: Key insights, challenges, and perspectives - A position paper from the French Society for Oncology Pharmacy (SFPO).
Florence Ranchon, Florian Slimano, Isabelle Borget, Mathieu Boulin, Christophe Bardin

Ann Pharm Fr· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The correlation of liquid biopsy genomic data to radiomics in colon, pancreatic, lung and prostatic cancer patients.
Antoine Italiano, Othilie Gautier, Jules Dupont, Tarek Assi, Lama Dawi, Isabelle Borget

Eur J Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Cost-Effectiveness Analysis of Gonadotropins Used for Ovarian Stimulation during Assisted Reproductive Technology Based on Data from the French Nationwide Claims Database (SNDS).
Isabelle Borget, Mehdi Benchaib, Philippine Poignant, Laetitia Rey, Gerard Harty

Gynecol Obstet Invest· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare resource utilization and costs in immunodeficient patients receiving subcutaneous Ig: Real-world evidence from France.
Guillaume Lefèvre, Isabelle Borget, Cinira Lefèvre, Chahrazed Maherzi, Arnaud Nucit

PLoS One· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methodological expectations for demonstration of health product effectiveness by observational studies.
Michel Cucherat, Olivier Demarcq, Olivier Chassany, Claire Le Jeunne, Isabelle Borget

Therapie· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up of the prospective randomised ESTIMABL2 trial.
Sophie Leboulleux, Claire Bournaud, Cecile N Chougnet, Livia Lamartina, Slimane Zerdoud, Isabelle Borget

Lancet Diabetes Endocrinol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Real-life evaluation of the care pathway of patients eligible for axicabtagene ciloleucel treatment: Analysis of a multicenter retrospective cohort (IMPA-CT study)].
Guillaume Cartron, Catherine Thieblemont, Isabelle Borget, Catherine Rioufol, Margaux Berthet

Bull Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Michel Cucherat, Olivier Demarcq, Olivier Chassany, Claire Le Jeunne, Isabelle Borget

Therapie· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Basal Insulinotherapy in Patients Living with Diabetes in France: The EF-BI Study.
Pierre Gourdy, Patrice Darmon, Isabelle Borget, Corinne Emery, Isabelle Bureau

Diabetes Ther· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Basal Insulinotherapy in Patients Living with Diabetes in France: The EF-BI Study.
Pierre Gourdy, Patrice Darmon, Isabelle Borget, Corinne Emery, Isabelle Bureau

Diabetes Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Early Access Reform on Oncology Innovation in France: Approvals, Patients, and Costs.
Tess Martin, Catherine Rioufol, Bertrand Favier, Nicolas Martelli, Isabelle Madelaine, Isabelle Borget

BioDrugs· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suitability of the Current Health Technology Assessment of Innovative Artificial Intelligence-Based Medical Devices: Scoping Literature Review.
Line Farah, Isabelle Borget, Nicolas Martelli, Alexandre Vallee

J Med Internet Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network.
Arnaud Jannin, Fabiola Giudici, Christelle de la Fouchardière, Abir Al Ghuzlan, Johanna Wassermann, Isabelle Borget

Thyroid· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MERAIODE: A Phase II Redifferentiation Trial with Trametinib and I in Metastatic Radioactive Iodine Refractory Mutated Differentiated Thyroid Cancer.
Sophie Leboulleux, Daniele Benisvy, David Taieb, Marie Attard, Claire Bournaud, Isabelle Borget

Thyroid· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Market Access Strategies for Artificial Intelligence-Based Medical Devices: Can We Standardize the Process to Faster Patient Access?
Line Farah, Isabelle Borget, Nicolas Martelli

Mayo Clin Proc Digit Health· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospital-based health technology assessment of innovative medical devices: insights from a nationwide survey in France.
Tess Martin, Alessandra Guercio, Hélène Besseau, Laure Huot, Pascale Guerre, Isabelle Borget

Int J Technol Assess Health Care· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Organizational Impact of Immunotherapies in Advanced Cancers in France.
Valentine Grumberg, Christos Chouaïd, Anne-Françoise Gaudin, Christophe Le Tourneau, Aurélien Marabelle, Isabelle Borget

JCO Glob Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer.
Sophie Leboulleux, Christine Do Cao, Slimane Zerdoud, Marie Attard, Claire Bournaud, Isabelle Borget

Clin Cancer Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trial.
Dana Hartl, Yann Godbert, Xavier Carrat, Stéphane Bardet, Audrey Lasne-Cardon, Isabelle Borget

Trials· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Performance, Interpretability, and Explainability in Artificial Intelligence-Based Health Technologies: What Healthcare Stakeholders Need to Know.
Line Farah, Juliette M Murris, Isabelle Borget, Agathe Guilloux, Nicolas M Martelli

Mayo Clin Proc Digit Health· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are current clinical studies on artificial intelligence-based medical devices comprehensive enough to support a full health technology assessment? A systematic review.
Line Farah, Julie Davaze-Schneider, Tess Martin, Pierre Nguyen, Isabelle Borget

Artif Intell Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trial.
Dana Hartl, Yann Godbert, Xavier Carrat, Stéphane Bardet, Audrey Lasne-Cardon, Isabelle Borget

Trials· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis